author_facet García-Martínez, Carolina
Humet, Marc
Planells-Cases, Rosa
Gomis, Ana
Caprini, Marco
Viana, Felix
De la Peña, Elvira
Sanchez-Baeza, Francisco
Carbonell, Teresa
De Felipe, Carmen
Pérez-Payá, Enrique
Belmonte, Carlos
Messeguer, Angel
Ferrer-Montiel, Antonio
García-Martínez, Carolina
Humet, Marc
Planells-Cases, Rosa
Gomis, Ana
Caprini, Marco
Viana, Felix
De la Peña, Elvira
Sanchez-Baeza, Francisco
Carbonell, Teresa
De Felipe, Carmen
Pérez-Payá, Enrique
Belmonte, Carlos
Messeguer, Angel
Ferrer-Montiel, Antonio
author García-Martínez, Carolina
Humet, Marc
Planells-Cases, Rosa
Gomis, Ana
Caprini, Marco
Viana, Felix
De la Peña, Elvira
Sanchez-Baeza, Francisco
Carbonell, Teresa
De Felipe, Carmen
Pérez-Payá, Enrique
Belmonte, Carlos
Messeguer, Angel
Ferrer-Montiel, Antonio
spellingShingle García-Martínez, Carolina
Humet, Marc
Planells-Cases, Rosa
Gomis, Ana
Caprini, Marco
Viana, Felix
De la Peña, Elvira
Sanchez-Baeza, Francisco
Carbonell, Teresa
De Felipe, Carmen
Pérez-Payá, Enrique
Belmonte, Carlos
Messeguer, Angel
Ferrer-Montiel, Antonio
Proceedings of the National Academy of Sciences
Attenuation of thermal nociception and hyperalgesia by VR1 blockers
Multidisciplinary
author_sort garcía-martínez, carolina
spelling García-Martínez, Carolina Humet, Marc Planells-Cases, Rosa Gomis, Ana Caprini, Marco Viana, Felix De la Peña, Elvira Sanchez-Baeza, Francisco Carbonell, Teresa De Felipe, Carmen Pérez-Payá, Enrique Belmonte, Carlos Messeguer, Angel Ferrer-Montiel, Antonio 0027-8424 1091-6490 Proceedings of the National Academy of Sciences Multidisciplinary http://dx.doi.org/10.1073/pnas.022285899 <jats:p> Vanilloid receptor subunit 1 (VR1) appears to play a critical role in the transduction of noxious chemical and thermal stimuli by sensory nerve endings in peripheral tissues. Thus, VR1 antagonists are useful compounds to unravel the contribution of this receptor to pain perception, as well as to induce analgesia. We have used a combinatorial approach to identify new, nonpeptidic channel blockers of VR1. Screening of a library of trimers of <jats:italic>N</jats:italic> -alkylglycines resulted in the identification of two molecules referred to as DD161515 { <jats:italic>N</jats:italic> -[2-(2-( <jats:italic>N</jats:italic> -methylpyrrolidinyl)ethyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} and DD191515 {[ <jats:italic>N</jats:italic> -[3-( <jats:italic>N</jats:italic> , <jats:italic>N</jats:italic> -diethylamino)propyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} that selectively block VR1 channel activity with micromolar efficacy, rivaling that characteristic of vanilloid-related inhibitors. These compounds appear to be noncompetitive VR1 antagonists that recognize a receptor site distinct from that of capsaicin. Intraperitoneal administration of both trialkylglycines into mice significantly attenuated thermal nociception as measured in the hot plate test. It is noteworthy that these compounds eliminated pain and neurogenic inflammation evoked by intradermal injection of capsaicin into the animal hindpaw, as well as the thermal hyperalgesia induced by tissue irritation with nitrogen mustard. In contrast, responses to mechanical stimuli were not modified by either compound. Modulation of sensory nerve fibers excitability appears to underlie the peptoid analgesic activity. Collectively, these results indicate that blockade of VR1 activity attenuates chemical and thermal nociception and hyperalgesia, supporting the tenet that this ionotropic receptor contributes to chemical and thermal sensitivity and pain perception <jats:italic>in vivo</jats:italic> . These trialkylglycine-based, noncompetitive VR1 antagonists may likely be developed into analgesics to treat inflammatory pain. </jats:p> Attenuation of thermal nociception and hyperalgesia by VR1 blockers Proceedings of the National Academy of Sciences
doi_str_mv 10.1073/pnas.022285899
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjAyMjI4NTg5OQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjAyMjI4NTg5OQ
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Proceedings of the National Academy of Sciences, 2002
imprint_str_mv Proceedings of the National Academy of Sciences, 2002
issn 0027-8424
1091-6490
issn_str_mv 0027-8424
1091-6490
language English
mega_collection Proceedings of the National Academy of Sciences (CrossRef)
match_str garciamartinez2002attenuationofthermalnociceptionandhyperalgesiabyvr1blockers
publishDateSort 2002
publisher Proceedings of the National Academy of Sciences
recordtype ai
record_format ai
series Proceedings of the National Academy of Sciences
source_id 49
title Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_unstemmed Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_full Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_fullStr Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_full_unstemmed Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_short Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_sort attenuation of thermal nociception and hyperalgesia by vr1 blockers
topic Multidisciplinary
url http://dx.doi.org/10.1073/pnas.022285899
publishDate 2002
physical 2374-2379
description <jats:p> Vanilloid receptor subunit 1 (VR1) appears to play a critical role in the transduction of noxious chemical and thermal stimuli by sensory nerve endings in peripheral tissues. Thus, VR1 antagonists are useful compounds to unravel the contribution of this receptor to pain perception, as well as to induce analgesia. We have used a combinatorial approach to identify new, nonpeptidic channel blockers of VR1. Screening of a library of trimers of <jats:italic>N</jats:italic> -alkylglycines resulted in the identification of two molecules referred to as DD161515 { <jats:italic>N</jats:italic> -[2-(2-( <jats:italic>N</jats:italic> -methylpyrrolidinyl)ethyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} and DD191515 {[ <jats:italic>N</jats:italic> -[3-( <jats:italic>N</jats:italic> , <jats:italic>N</jats:italic> -diethylamino)propyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} that selectively block VR1 channel activity with micromolar efficacy, rivaling that characteristic of vanilloid-related inhibitors. These compounds appear to be noncompetitive VR1 antagonists that recognize a receptor site distinct from that of capsaicin. Intraperitoneal administration of both trialkylglycines into mice significantly attenuated thermal nociception as measured in the hot plate test. It is noteworthy that these compounds eliminated pain and neurogenic inflammation evoked by intradermal injection of capsaicin into the animal hindpaw, as well as the thermal hyperalgesia induced by tissue irritation with nitrogen mustard. In contrast, responses to mechanical stimuli were not modified by either compound. Modulation of sensory nerve fibers excitability appears to underlie the peptoid analgesic activity. Collectively, these results indicate that blockade of VR1 activity attenuates chemical and thermal nociception and hyperalgesia, supporting the tenet that this ionotropic receptor contributes to chemical and thermal sensitivity and pain perception <jats:italic>in vivo</jats:italic> . These trialkylglycine-based, noncompetitive VR1 antagonists may likely be developed into analgesics to treat inflammatory pain. </jats:p>
container_issue 4
container_start_page 2374
container_title Proceedings of the National Academy of Sciences
container_volume 99
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792338871953915909
geogr_code not assigned
last_indexed 2024-03-01T15:38:46.976Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Attenuation+of+thermal+nociception+and+hyperalgesia+by+VR1+blockers&rft.date=2002-02-19&genre=article&issn=1091-6490&volume=99&issue=4&spage=2374&epage=2379&pages=2374-2379&jtitle=Proceedings+of+the+National+Academy+of+Sciences&atitle=Attenuation+of+thermal+nociception+and+hyperalgesia+by+VR1+blockers&aulast=Ferrer-Montiel&aufirst=Antonio&rft_id=info%3Adoi%2F10.1073%2Fpnas.022285899&rft.language%5B0%5D=eng
SOLR
_version_ 1792338871953915909
author García-Martínez, Carolina, Humet, Marc, Planells-Cases, Rosa, Gomis, Ana, Caprini, Marco, Viana, Felix, De la Peña, Elvira, Sanchez-Baeza, Francisco, Carbonell, Teresa, De Felipe, Carmen, Pérez-Payá, Enrique, Belmonte, Carlos, Messeguer, Angel, Ferrer-Montiel, Antonio
author_facet García-Martínez, Carolina, Humet, Marc, Planells-Cases, Rosa, Gomis, Ana, Caprini, Marco, Viana, Felix, De la Peña, Elvira, Sanchez-Baeza, Francisco, Carbonell, Teresa, De Felipe, Carmen, Pérez-Payá, Enrique, Belmonte, Carlos, Messeguer, Angel, Ferrer-Montiel, Antonio, García-Martínez, Carolina, Humet, Marc, Planells-Cases, Rosa, Gomis, Ana, Caprini, Marco, Viana, Felix, De la Peña, Elvira, Sanchez-Baeza, Francisco, Carbonell, Teresa, De Felipe, Carmen, Pérez-Payá, Enrique, Belmonte, Carlos, Messeguer, Angel, Ferrer-Montiel, Antonio
author_sort garcía-martínez, carolina
container_issue 4
container_start_page 2374
container_title Proceedings of the National Academy of Sciences
container_volume 99
description <jats:p> Vanilloid receptor subunit 1 (VR1) appears to play a critical role in the transduction of noxious chemical and thermal stimuli by sensory nerve endings in peripheral tissues. Thus, VR1 antagonists are useful compounds to unravel the contribution of this receptor to pain perception, as well as to induce analgesia. We have used a combinatorial approach to identify new, nonpeptidic channel blockers of VR1. Screening of a library of trimers of <jats:italic>N</jats:italic> -alkylglycines resulted in the identification of two molecules referred to as DD161515 { <jats:italic>N</jats:italic> -[2-(2-( <jats:italic>N</jats:italic> -methylpyrrolidinyl)ethyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} and DD191515 {[ <jats:italic>N</jats:italic> -[3-( <jats:italic>N</jats:italic> , <jats:italic>N</jats:italic> -diethylamino)propyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} that selectively block VR1 channel activity with micromolar efficacy, rivaling that characteristic of vanilloid-related inhibitors. These compounds appear to be noncompetitive VR1 antagonists that recognize a receptor site distinct from that of capsaicin. Intraperitoneal administration of both trialkylglycines into mice significantly attenuated thermal nociception as measured in the hot plate test. It is noteworthy that these compounds eliminated pain and neurogenic inflammation evoked by intradermal injection of capsaicin into the animal hindpaw, as well as the thermal hyperalgesia induced by tissue irritation with nitrogen mustard. In contrast, responses to mechanical stimuli were not modified by either compound. Modulation of sensory nerve fibers excitability appears to underlie the peptoid analgesic activity. Collectively, these results indicate that blockade of VR1 activity attenuates chemical and thermal nociception and hyperalgesia, supporting the tenet that this ionotropic receptor contributes to chemical and thermal sensitivity and pain perception <jats:italic>in vivo</jats:italic> . These trialkylglycine-based, noncompetitive VR1 antagonists may likely be developed into analgesics to treat inflammatory pain. </jats:p>
doi_str_mv 10.1073/pnas.022285899
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjAyMjI4NTg5OQ
imprint Proceedings of the National Academy of Sciences, 2002
imprint_str_mv Proceedings of the National Academy of Sciences, 2002
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0027-8424, 1091-6490
issn_str_mv 0027-8424, 1091-6490
language English
last_indexed 2024-03-01T15:38:46.976Z
match_str garciamartinez2002attenuationofthermalnociceptionandhyperalgesiabyvr1blockers
mega_collection Proceedings of the National Academy of Sciences (CrossRef)
physical 2374-2379
publishDate 2002
publishDateSort 2002
publisher Proceedings of the National Academy of Sciences
record_format ai
recordtype ai
series Proceedings of the National Academy of Sciences
source_id 49
spelling García-Martínez, Carolina Humet, Marc Planells-Cases, Rosa Gomis, Ana Caprini, Marco Viana, Felix De la Peña, Elvira Sanchez-Baeza, Francisco Carbonell, Teresa De Felipe, Carmen Pérez-Payá, Enrique Belmonte, Carlos Messeguer, Angel Ferrer-Montiel, Antonio 0027-8424 1091-6490 Proceedings of the National Academy of Sciences Multidisciplinary http://dx.doi.org/10.1073/pnas.022285899 <jats:p> Vanilloid receptor subunit 1 (VR1) appears to play a critical role in the transduction of noxious chemical and thermal stimuli by sensory nerve endings in peripheral tissues. Thus, VR1 antagonists are useful compounds to unravel the contribution of this receptor to pain perception, as well as to induce analgesia. We have used a combinatorial approach to identify new, nonpeptidic channel blockers of VR1. Screening of a library of trimers of <jats:italic>N</jats:italic> -alkylglycines resulted in the identification of two molecules referred to as DD161515 { <jats:italic>N</jats:italic> -[2-(2-( <jats:italic>N</jats:italic> -methylpyrrolidinyl)ethyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} and DD191515 {[ <jats:italic>N</jats:italic> -[3-( <jats:italic>N</jats:italic> , <jats:italic>N</jats:italic> -diethylamino)propyl]glycyl]-[ <jats:italic>N</jats:italic> -[2,4-dichlorophenethyl]glycyl]- <jats:italic>N</jats:italic> -(2,4-dichlorophenethyl)glycinamide} that selectively block VR1 channel activity with micromolar efficacy, rivaling that characteristic of vanilloid-related inhibitors. These compounds appear to be noncompetitive VR1 antagonists that recognize a receptor site distinct from that of capsaicin. Intraperitoneal administration of both trialkylglycines into mice significantly attenuated thermal nociception as measured in the hot plate test. It is noteworthy that these compounds eliminated pain and neurogenic inflammation evoked by intradermal injection of capsaicin into the animal hindpaw, as well as the thermal hyperalgesia induced by tissue irritation with nitrogen mustard. In contrast, responses to mechanical stimuli were not modified by either compound. Modulation of sensory nerve fibers excitability appears to underlie the peptoid analgesic activity. Collectively, these results indicate that blockade of VR1 activity attenuates chemical and thermal nociception and hyperalgesia, supporting the tenet that this ionotropic receptor contributes to chemical and thermal sensitivity and pain perception <jats:italic>in vivo</jats:italic> . These trialkylglycine-based, noncompetitive VR1 antagonists may likely be developed into analgesics to treat inflammatory pain. </jats:p> Attenuation of thermal nociception and hyperalgesia by VR1 blockers Proceedings of the National Academy of Sciences
spellingShingle García-Martínez, Carolina, Humet, Marc, Planells-Cases, Rosa, Gomis, Ana, Caprini, Marco, Viana, Felix, De la Peña, Elvira, Sanchez-Baeza, Francisco, Carbonell, Teresa, De Felipe, Carmen, Pérez-Payá, Enrique, Belmonte, Carlos, Messeguer, Angel, Ferrer-Montiel, Antonio, Proceedings of the National Academy of Sciences, Attenuation of thermal nociception and hyperalgesia by VR1 blockers, Multidisciplinary
title Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_full Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_fullStr Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_full_unstemmed Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_short Attenuation of thermal nociception and hyperalgesia by VR1 blockers
title_sort attenuation of thermal nociception and hyperalgesia by vr1 blockers
title_unstemmed Attenuation of thermal nociception and hyperalgesia by VR1 blockers
topic Multidisciplinary
url http://dx.doi.org/10.1073/pnas.022285899